
Exploring the Next Generation of Metabolic Health Innovations
In this episode of the Ageless Future Podcast, Cade Archibald explores emerging developments in metabolic health, comparing two investigational therapies—an oral GLP-1 medication (orforglipron) and the injectable triple-agonist retatrutide. The discussion highlights how these therapies differ in delivery methods, mechanisms of action, and areas of ongoing clinical research, while emphasizing that treatment decisions should be individualized and made with a healthcare provider. The episode also encourages listeners to look beyond weight alone by tracking personal health metrics, adopting…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.